ELK1 and colonic neoplasm: Kong et al. in 2023 reported that AKAP95 is correlated to the activation of the BRAF-MEK-MAPK pathway, acting via phosphorylation of ELK1 and significantly affects immune cell infiltration and colon cancer patient survival [118].